Video

Scrutiny Continues to Grow Around the Cost of Specialty Drugs

Author(s):

Lauren Santye, Assistant Editor

Marc O'Connor, COO and chief strategy officer of Curant Health, discusses increased oversight of specialty medication pricing.

Marc O'Connor, COO and chief strategy officer of Curant Health, discusses increased oversight of specialty medication pricing.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image Credit: shidlovski | stock.adobe.com
Related Content
Compression socks with edema therapy concept. Futuristic socks with glowing patterns showcasing foot anatomy.
September 16th 2025

FDA Approves Bumetanide Nasal Spray for Edema With Heart Failure, Hepatic and Renal Disease

Luke Halpern, Assistant Editor
Pharmacy Focus: Role of Pharmacists in Proper Inhaler Usage
September 16th 2025

Pharmacy Focus: Role of Pharmacists in Proper Inhaler Usage

Jennifer Griffin, PharmD, MS Luke Halpern, Assistant Editor
Atopic dermatitis. Red, itchy hands with blisters seen by a dermatologist
September 16th 2025

Amlitelimab Meaningfully Clears Skin in Moderate-to-Severe Atopic Dermatitis

Luke Halpern, Assistant Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
September 16th 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Panel of health care professionals -- Image credit: Africa Studio | stock.adobe.com
September 16th 2025

Decoding Most Favored Nation: Expert Insights on the Impacts to Patients, Pharma, and Innovation

Brian Corvino Neal Masia, PhD Ali Pashazadeh George Van Antwerp, MBA Ned Milenkovich, PharmD, JD Gillian McGovern, Associate Editor
Pharmacist Spotlight: Luke Witkowski, PharmD
September 16th 2025

Pharmacist Spotlight: Luke Witkowski, PharmD

PT Staff Luke Witkowski, PharmD
© 2025 MJH Life Sciences

All rights reserved.